Clinical trial

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

NCT06492954

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-10-01

PhasePHASE1

Study timeline

Study start (estimated)2026-10-01Date precision: month

Registry last updated2026-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Osteosarcomaunresolved

Pulmonary Recurrence of Osteosarcomaunresolved

Interventions

Surgical ResectionPROCEDURE

Stereotactic Body Radiation Therapy (SBRT)RADIATION

AtezolizumabDRUG · verified · RxNorm: atezolizumab

Sponsors & collaborators

Emory Universitylead sponsor

Genentech, Inc.collaborator

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06492954 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.